"None of these advances are close at hand, and some are unlikely to ever come about," the article stated, calling most of the company’s medical claims "highly speculative."
Gold climbed, recovering from Thursday’s drop, as the dollar sank with investors weighing the impact of the Federal Reserve’s new approach to setting U.S. monetary policy.